The best they are able to do is cope with the problems and drive you to keep using them over and over. And that is what the market wants. You are wanted by them to keep buying their products to allow them to stay in business. They don’t sell remedies because they need you to keep coming back to them. A healed patient is no longer a customer! If you ever ask a doctor if indeed they would ever deal with the symptoms of their individuals disease, they might reply something to the result of ‘Of course not. Treating just the symptoms means the real problems are still there.’ If we don’t deal with the real problems, the nagging complications never go away, obviously.Related StoriesDisclosing genetic risk for CHD outcomes in lower low-density lipoprotein cholesterolUnderstanding how schizophrenia affects workings of the brainSt. We were extremely encouraged to find that treatment with lomitapide can be connected with minimal to moderate hepatic fats accumulation at 26 weeks that seems to stabilize or also decrease after twelve months of treatment. We believe these outcomes suggest that lomitapide could turn into a potential component of the treatment regimen for severe dyslipidemic patients who are faced with limited treatment plans today, as well as other high risk patients that have raised chlesterol while acquiring existing lipid-lowering medicines.m.m.